Siteman Cancer Center, Washington University — St Louis, Missouri

Siteman Cancer Center, Washington University is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Siteman Cancer Center, Washington University has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma.

Sponsors: University of Nebraska, Advenchen Pharmaceuticals, LLC., Duke University.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Siteman Cancer Center, Washington University?

Siteman Cancer Center, Washington University has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Siteman Cancer Center, Washington University conducted?

Siteman Cancer Center, Washington University has 3 clinical trials on record, with 1 currently active. Their work covers Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma.

Is Siteman Cancer Center, Washington University accredited by Crixeo Health?

Siteman Cancer Center, Washington University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Siteman Cancer Center, Washington University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.